Drug firm Dr Reddy’s Laboratories today said state-run Life Insurance Corporation (LIC) has cut its stake in the company to 6.31 per cent by selling shares worth Rs 875.29 crore in the open market.
LIC held 8.38 per cent stake in the pharma major before offloading about 35.25 lakh shares, accounting for around 2.07 per cent shareholding.
The insurer has reduced its stake to 6.31 per cent through the open market sales, Dr Reddy’s Laboratories said in a filing to the BSE.
LIC has sold 35.25 lakh shares via market sale, the filing said.
Following the transaction, LIC’s total shareholding in the company has come down to 6.31 per cent from 8.38 per cent, it added.
Dr Reddy’s scrip closed at Rs 1,913.10 on the BSE, down 0.45 per cent.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.